150 related articles for article (PubMed ID: 36858531)
1. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
2. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Delivery of Plasmid DNA Using Amphipathic Helical Cell-Penetrating Peptides Containing Dipropylglycine.
Naka M; Umeno T; Shibuya M; Yamaberi Y; Ueda A; Tanaka M; Takemoto H; Oba M
Chem Pharm Bull (Tokyo); 2024; 72(5):512-517. PubMed ID: 38811213
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
5. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
6. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Kim S; Hyun S; Lee Y; Lee Y; Yu J
Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy.
Vasconcelos L; Lehto T; Madani F; Radoi V; Hällbrink M; Vukojević V; Langel Ü
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):491-504. PubMed ID: 28962904
[TBL] [Abstract][Full Text] [Related]
8. Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for targeted delivery of small interfering RNA.
Wada SI; Iwata M; Ozaki Y; Ozaki T; Hayashi J; Urata H
Bioorg Med Chem; 2016 Sep; 24(18):4478-4485. PubMed ID: 27480031
[TBL] [Abstract][Full Text] [Related]
9. The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides.
Pärnaste L; Arukuusk P; Langel K; Tenson T; Langel Ü
Mol Ther Nucleic Acids; 2017 Jun; 7():1-10. PubMed ID: 28624185
[TBL] [Abstract][Full Text] [Related]
10. Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study.
Rathnayake PV; Gunathunge BG; Wimalasiri PN; Karunaratne DN; Ranatunga RJ
J Biophys; 2017; 2017():1059216. PubMed ID: 28321253
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
12. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
13. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
[TBL] [Abstract][Full Text] [Related]
14. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
Jafari M; Xu W; Naahidi S; Chen B; Chen P
J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of Aib-containing amphipathic helical peptide-cyclic RGD conjugates as carriers for siRNA delivery.
Wada SI; Takesada A; Nagamura Y; Sogabe E; Ohki R; Hayashi J; Urata H
Bioorg Med Chem Lett; 2017 Dec; 27(24):5378-5381. PubMed ID: 29157863
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
17. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides for siRNA delivery to glioblastomas.
Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
[TBL] [Abstract][Full Text] [Related]
19. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
Jafari M; Karunaratne DN; Sweeting CM; Chen P
Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
[TBL] [Abstract][Full Text] [Related]
20. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
